Abstract
Myocardial interstitial expansion seems to be fundamental to the process of adverse left ventricular remodeling. Recent evidence has shown that the extracellular volume fraction (ECV) derived from cardiovascular magnetic resonance (CMR) can be used as a noninvasive method to quantify myocardial interstitial volume in a range of heart diseases. Our aim was to determine whether ECV is increased in asymptomatic orthotopic heart transplant (HTx) patients and its associations with clinical features and T2 values, the elevation of which usually suggests myocardial edema. A group of asymptomatic cardiac transplant recipients and some healthy volunteers were invited to undergo a comprehensive CMR scan, including cine imaging, late gadolinium enhancement, T1 mapping and T2 mapping, from March to June in 2017. All quantitative measurements were averaged from the basal and mid short-axis slices. Fifty-eight recipients (mean age, 42.7 ± 11.5 years; 13 females), at a median of 1.8 years (0.3–6.3 years) after HTx, and 20 healthy volunteers (mean age, 39.5 ± 11.3 years; 5 females) underwent the CMR scan. We found that both the ECV and T2 values were higher in the post-HTx group (ECV: 26.7 ± 3.3 vs. 24.6 ± 2.5%, p = 0.008; T2: 47.7 ± 2.8 vs. 44.5 ± 1.6 ms, p < 0.001) than in the control group. ECV was moderately associated with organ ischemia time at the time of transplantation but not with the hemodynamics parameter or the time since transplantation at CMR. Additionally, a relatively strong correlation was observed between ECV and T2 (r = 0.7, p < 0.001). So, our conclusion is that CMR-derived ECV is increased and associated with peri-transplant ischemia time in asymptomatic HTx patients. And the strong correlation of ECV with elevated T2 indicates that myocardial edema may be an important part of the extracellular volume expansion after heart transplantation.
Similar content being viewed by others
Abbreviations
- ECV:
-
Extracellular volume fraction
- CMR:
-
Cardiovascular magnetic resonance
- HTx:
-
Heart transplant
- LGE:
-
Late gadolinium enhancement
- MF:
-
Myocardial fibrosis
- EMB:
-
Endomyocardial biopsy
- CAV:
-
Cardiac allograft vasculopathy
- ACR:
-
Acute allograft rejection
- CCTA:
-
Coronary computed tomography angiography
- CAG:
-
Coronary angiography
- SSFP:
-
Cine steady-state free precession
- MOLLI:
-
Modified look-locker inversion recovery
- LV:
-
Left ventricle
- LVEF:
-
LV ejection fraction
- LVEDV:
-
LV end-diastolic volume
- LVESV:
-
LV end-systolic volume
- LVM:
-
LV mass
- IVS:
-
Interventricular septum
- RV:
-
Right ventricle
References
Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Quaini F, Sonnenblick EH, Olivetti G, Anversa P (1994) Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 89(1):151–163. https://doi.org/10.1161/01.cir.89.1.151
Swynghedauw B (1999) Molecular mechanisms of myocardial remodeling. Springer, New York
Moreo A, Ambrosio G, Chiara BD, Pu M, Tran T, Mauri F, Raman SV (2009) Influence of myocardial fibrosis on left ventricular diastolic function noninvasive assessment by cardiac magnetic resonance and echo. Circ Cardiovasc Imaging 2(6):437
Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA, Shakesprere J, Kellman P, Shroff SG, Schwartzman DS (2012) Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation 126(10):1206
Youn JC, Hong YJ, Lee HJ, Han K, Shim CY, Hong GR, Suh YJ, Hur J, Kim YJ, Choi BW (2017) Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study. Eur Radiol 27(9):3924–3933
Díez J, Querejeta R, López B, González A, Larman M, Ubago JLM (2002) Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 105(21):2512–2517
Izawa H, Murohara T, Nagata K, Isobe S, Asano H, Amano T, Ichihara S, Kato T, Ohshima S, Murase Y (2005) Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study. Circulation 112(19):2940
Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, Gatehouse PD, Arai AE, Friedrich MG, Neubauer S (2013) Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 15(1):92
Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, Mcgregor C, Moon JC (2010) Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 122(2):138
Sibley CT, Noureldin RA, Gai N, Nacif MS, Liu S, Turkbey EB, Mudd JO, Rj VDG, Lima JA, Halushka MK (2012) T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. Radiology 265(3):724–732
Miller CA, Naish JH, Bishop P, Coutts G, Clark D, Zhao S, Ray SG, Yonan N, Williams SG, Flett AS (2013) Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging 6(4):e25
Diao K, Yang Z, Xu H, Liu X, Zhang Q, Shi K, Jiang L, Xie L, Wen L, Guo Y (2017) Histologic validation of myocardial fibrosis measured by T1 mapping: a systematic review and meta-analysis. J Cardiovasc Magn Reson 18(1):92
Gramley F, Lorenzen J, Pezzella F, Kettering K, Himmrich E, Plumhans C, Koellensperger E, Munzel T (2009) Hypoxia and myocardial remodeling in human cardiac allografts: a time-course study. J Heart Lung Transplant 28(11):1119–1126
Armstrong AT, Binkley PF, Baker PB, Myerowitz PD, Leier CV (1998) Quantitative investigation of cardiomyocyte hypertrophy and myocardial fibrosis over 6 years after cardiac transplantation. J Am Coll Cardiol 32(3):704
Ide S, Riesenkampff E, Chiasson DA, Dipchand AI, Kantor PF, Chaturvedi RR, Yoo SJ, Grossewortmann L (2017) Histological validation of cardiovascular magnetic resonance T1 mapping markers of myocardial fibrosis in paediatric heart transplant recipients. J Cardiovasc Magn Reson 19(1):10
Feingold B, Salgado CM, Reyes-Múgica M, Drant SE, Miller SA, Kennedy M, Kellman P, Schelbert EB, Wong TC (2017) Diffuse myocardial fibrosis among healthy pediatric heart transplant recipients: correlation of histology, cardiovascular magnetic resonance, and clinical phenotype. Pediatr Transplant 21 (5):e12986. https://doi.org/10.1111/petr.12986
Miller CA, Sarma J, Naish JH, Yonan N, Williams SG, Shaw SM, Clark D, Pearce K, Stout M, Potluri R, Borg A, Coutts G, Chowdhary S, McCann GP, Parker GJM, Ray SG, Schmitt M (2014) Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy. J Am Coll Cardiol 63(8):799–808. https://doi.org/10.1016/j.jacc.2013.07.119
Pickering JG, Boughner DR (1990) Fibrosis in the transplanted heart and its relation to donor ischemic time. Assessment with polarized light microscopy and digital image analysis. Circulation 81(3):949
Coelho-Filho OR, Shah R, Lavagnoli CFR, Barros JC, Neilan TG, Murthy VL, Oliveira PPMD, Souza JRM (2016) Myocardial tissue remodeling after orthotopic heart transplantation: a pilot cardiac magnetic resonance study. Int J Cardiovasc Imaging 34:15–24
Feingold B, Picarsic J, Lesniak A, Popp BA, Woodtrageser MA, Demetris AJ (2017) Late graft dysfunction after pediatric heart transplantation is associated with fibrosis and microvasculopathy by automated, digital whole-slide analysis. J Heart Lung Transplant 36:1336–1343
Shivraman G, Yiu-Cho C, Ali M, Georgeta M, Sanjay R, Raman SV, Simonetti OP (2009) T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson 11(1):56
Tahir E, Sinn M, Bohnen S, Avanesov M, Säring D, Stehning C, Schnackenburg B, Eulenburg C, Wien J, Radunski UK (2017) Acute versus chronic myocardial infarction: diagnostic accuracy of quantitative native t1 and t2 mapping versus assessment of edema on standard t2-weighted cardiovascular MR images for differentiation. Radiology 285(1):83
Markl M, Rustogi R, Galizia M, Goyal A, Collins J, Usman A, Jung B, Foell D, Carr J (2013) Myocardial T2-mapping and velocity mapping: changes in regional left ventricular structure and function after heart transplantation. Magn Reson Med 70(2):517–526
Miller CA, Naish JH, Shaw SM, Yonan N, Williams SG, Clark D, Ainslie MP, Borg A, Coutts G, Parker GJ (2014) Multiparametric cardiovascular magnetic resonance surveillance of acute cardiac allograft rejection and characterisation of transplantation-associated myocardial injury. J Cardiovasc Magn Reson 16(1):1–11
Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E (2013) Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson 15(1):91
Braggion-Santos MF, Andre F, Lossnitzer D, Hofmann E, Simpfendörfer J, Dösch A, Katus HA, Steen H (2014) Prevalence of different forms of infarct-atypical late gadolinium enhancement in patients early and late after heart transplantation. Clin Res Cardiol 103(1):57–63
Rowan RA, Billingham ME (1990) Pathologic changes in the long-term transplanted heart: a morphometric study of myocardial hypertrophy, vascularity, and fibrosis. Hum Pathol 21(7):767
Sado DM, Flett AS, Banypersad SM, White SK, Maestrini V, Quarta G, Lachmann RH, Murphy E, Mehta A, Hughes DA (2012) Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 98(19):1436–1441
Baeßler B, Schaarschmidt F, Stehning C, Schnackenburg B, Maintz D, Bunck AC (2015) A systematic evaluation of three different cardiac T2-mapping sequences at 1.5 and 3T in healthy volunteers. Eur J Radiol 84(11):2161–2170
Steen H, Merten C, Refle S, Klingenberg R, Dengler T, Giannitsis E, Katus HA (2008) Prevalence of different gadolinium enhancement patterns in patients after heart transplantation. J Am Coll Cardiol 52(14):1160–1167
Maceira AM, Joshi J, Prasad SK, Moon JC, Perugini E, Harding I, Sheppard MN, Poolewilson PA, Hawkins PN, Pennell DJ (2005) Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111(2):186
Moon JC, Sheppard M, Reed E, Lee P, Elliott PM, Pennell DJ (2006) The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. J Cardiovasc Magn Reson 8(3):479–482
Moon JC, Mundy HR, Lee PJ, Mohiaddin RH, Pennell DJ (2003) Images in cardiovascular medicine. Myocardial fibrosis in glycogen storage disease type III. Circulation 107(7):e47
Atkison P, Joubert G, Barron A, Grant D (1995) Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients. Lancet 345(8954):894–896
Mano A, Nakatani T, Yahata Y, Kato T, Hashimoto S, Wada K, Ishibashi-Ueda H (2009) Reversible myocardial hypertrophy induced by tacrolimus in a pediatric heart transplant recipient: case report. Transplant Proc 41(9):3831–3834
Coelho-Filho OR, Shah R, Neilan TG, Mattos Souza JR, Barros Júnior JC, Lavagnoli CFR, Silveira-Filho LdM, de Oliveira PPM, Severino ES, Jerosch-Herold M, Petrucci O (2015) Characterization of both myocardial extracellular volume expansion and myocyte hypertrophy by CMR in heart transplantation recipients without active rejection: implications for early cardiac remodeling. J Cardiovasc Magn Reson 17(1):1–2
Funding
This study was partly supported by the National Natural Science Foundation of China (Grant Nos. 81701653 and WJ2017Q019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The study was approved by the local research ethics board (Tongji Medical College Ethics Board, Huazhong University of Science and Technology) and in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Informed consent
Written informed consent was obtained from each patient.
Rights and permissions
About this article
Cite this article
Yuan, Y., Cai, J., Cui, Y. et al. CMR-derived extracellular volume fraction (ECV) in asymptomatic heart transplant recipients: correlations with clinical features and myocardial edema. Int J Cardiovasc Imaging 34, 1959–1967 (2018). https://doi.org/10.1007/s10554-018-1421-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-018-1421-2